Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(4.49)
# 302
Out of 5,120 analysts
76
Total ratings
50.67%
Success rate
33.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AURA Aura Biosciences | Assumes: Buy | $22 | $5.88 | +274.15% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $2.51 | +298.41% | 1 | May 15, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $8.28 | +383.09% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.02 | +880.39% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $10.61 | -43.45% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $5.85 | +122.22% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $20 | $15.10 | +32.45% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $7.04 | +226.70% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $54.34 | +38.02% | 13 | Apr 28, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $36 | $11.50 | +213.04% | 14 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.68 | +2,110.76% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $10.00 | +150.00% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $46.61 | +7.27% | 13 | Nov 26, 2024 |
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $5.88
Upside: +274.15%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $2.51
Upside: +298.41%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $8.28
Upside: +383.09%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.02
Upside: +880.39%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $10.61
Upside: -43.45%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $5.85
Upside: +122.22%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $20
Current: $15.10
Upside: +32.45%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $7.04
Upside: +226.70%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $54.34
Upside: +38.02%
Day One Biopharmaceuticals
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $11.50
Upside: +213.04%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.68
Upside: +2,110.76%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $10.00
Upside: +150.00%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $46.61
Upside: +7.27%